We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
-11.07%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$31B
AUM Growth
-$3.58B
(-10%)
Cap. Flow
+$650M
Cap. Flow
% of AUM
2.1%
Top 10 Holdings %
Top 10 Hldgs %
21.79%
Holding
3,848
New
181
Increased
1,290
Reduced
1,412
Closed
201
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Copart
CPRT
|
+$122M |
| 2 |
Toro Company
TTC
|
+$88.2M |
| 3 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$73.9M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$65.9M |
| 5 |
Schwab US REIT ETF
SCHH
|
+$45.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$54.5M |
| 2 |
PX
Praxair Inc
PX
|
+$49.2M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$42.1M |
| 4 |
GE Aerospace
GE
|
+$28.5M |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$20.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.21% |
| 2 | Industrials | 11.04% |
| 3 | Healthcare | 10.93% |
| 4 | Technology | 9.83% |
| 5 | Consumer Staples | 6.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Ligand Pharmaceuticals
LGND
$5.94B
| $1.35M | ﹤0.01% |
15,975
+3,422
| +27% | +$365K |
|
877
Vanguard Morningstar Large-Cap ETF
VV
$52.1B
| $1.34M | ﹤0.01% |
11,697
-295
| -2% | -$36.5K |
|
878
US Physical Therapy
USPH
$1.22B
| $1.33M | ﹤0.01% |
13,018
+334
| +3% | +$37.1K |
|
879
iShares Gold Trust
IAU
$63.8B
| $1.33M | ﹤0.01% |
53,950
-2,463
| -4% | -$58K |
|
|
B
880
DELISTED
Barnes Group Inc.
B
| $1.32M | ﹤0.01% |
24,687
-32,129
| -57% | -$1.89M |
|
|
DOCU
881
DocuSign
DOCU
$10.4B
| $1.32M | ﹤0.01% |
33,004
+9,579
| +41% | +$403K |
|
|
CY
882
DELISTED
Cypress Semiconductor
CY
| $1.32M | ﹤0.01% |
103,881
+1,471
| +1% | +$19.5K |
|
|
LLL
883
DELISTED
L3 Technologies, Inc.
LLL
| $1.32M | ﹤0.01% |
7,587
-83
| -1% | -$16K |
|
884
UDR
UDR
$12.3B
| $1.32M | ﹤0.01% |
33,200
+2,401
| +8% | +$97K |
|
885
Quest Diagnostics
DGX
$25.9B
| $1.31M | ﹤0.01% |
15,804
-2,244
| -12% | -$210K |
|
886
Nexstar Media Group
NXST
$5.88B
| $1.31M | ﹤0.01% |
16,716
-1,396
| -8% | -$110K |
|
887
Murphy Oil
MUR
$5.48B
| $1.31M | ﹤0.01% |
56,139
+2,987
| +6% | +$91.6K |
|
|
AMTD
888
DELISTED
TD Ameritrade Holding Corp
AMTD
| $1.31M | ﹤0.01% |
26,774
-1,048
| -4% | -$53.4K |
|
889
Zions Bancorporation
ZION
$10.1B
| $1.31M | ﹤0.01% |
32,103
-8,268
| -20% | -$385K |
|
|
HTLF
890
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.31M | ﹤0.01% |
29,757
+362
| +1% | +$19K |
|
891
Healthpeak Properties
DOC
$15.2B
| $1.3M | ﹤0.01% |
46,742
+312
| +0.7% | +$8.64K |
|
892
Emergent Biosolutions
EBS
$375M
| $1.3M | ﹤0.01% |
21,953
-2,104
| -9% | -$136K |
|
893
Host Hotels & Resorts
HST
$17.2B
| $1.3M | ﹤0.01% |
77,880
-1,958
| -2% | -$36.7K |
|
894
Newmont
NEM
$101B
| $1.3M | ﹤0.01% |
37,417
+1,717
| +5% | +$55.7K |
|
895
Moelis & Co
MC
$5.08B
| $1.29M | ﹤0.01% |
37,659
+11,873
| +46% | +$504K |
|
896
Cedar Fair
FUN
$1.81B
| $1.29M | ﹤0.01% |
27,321
-2,425
| -8% | -$127K |
|
|
DNB
897
DELISTED
Dun & Bradstreet
DNB
| $1.29M | ﹤0.01% |
9,026
-241
| -3% | -$34.4K |
|
898
Astec Industries
ASTE
$1.18B
| $1.29M | ﹤0.01% |
42,661
+28,880
| +210% | +$1.09M |
|
|
CYBR
899
DELISTED
CyberArk
CYBR
| $1.28M | ﹤0.01% |
17,328
+741
| +4% | +$52.9K |
|
900
Zurn Elkay Water Solutions
ZWS
$8.31B
| $1.28M | ﹤0.01% |
116,140
+28,720
| +33% | +$372K |
|
Similar funds
US Bancorp's Q4 2018 Portfolio in Review
As of Q4 2018, US Bancorp held 3,848 positions worth $31B, down 10% from $34.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
US Bancorp's Q4 2018 filing shows 181 new, 1,290 increased, 1,412 reduced and 201 closed positions. Its largest new stake was Linde: 258,827 shares worth $40.4M. The largest sale was iShares Core US Aggregate Bond ETF, an estimated $54.5M.
By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Industrials and Healthcare.
- US Bancorp's largest Q4 2018 buy was Linde: 258,827 shares worth $40.4M.
- US Bancorp added most to Copart in Q4 2018, an estimated $122M increase.
- US Bancorp's biggest Q4 2018 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $54.5M.
- US Bancorp fully exited Praxair Inc in Q4 2018, selling an estimated $49.2M.
- US Bancorp's ten largest holdings make up 22% of its $31B portfolio in Q4 2018.
- US Bancorp opened 181 new positions and closed 201 in Q4 2018.
- US Bancorp's portfolio value fell 10% quarter-over-quarter to $31B.
Based on US Bancorp's 13F filing for Q4 2018, filed 13 Feb 2019.